Last: | $77.60 |
---|---|
Change Percent: | -0.47% |
Open: | $76.87 |
Close: | $77.60 |
High: | $77.685 |
Low: | $76.735 |
Volume: | 4,848,699 |
Last Trade Date Time: | 03/14/2025 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$77.6 | $76.87 | $77.6 | $77.685 | $76.735 | 4,848,699 | 03-14-2025 |
$76.51 | $76.7 | $76.51 | $77.03 | $76.17 | 7,431,213 | 03-13-2025 |
$75.57 | $75.27 | $75.57 | $75.785 | $74.68 | 6,674,831 | 03-12-2025 |
$74.24 | $75.52 | $74.24 | $75.67 | $74.18 | 6,108,855 | 03-11-2025 |
$75.99 | $76.11 | $75.99 | $76.965 | $75.47 | 6,254,739 | 03-10-2025 |
$77.5 | $77.69 | $77.5 | $78.25 | $77.2802 | 7,023,441 | 03-07-2025 |
$77.47 | $77.39 | $77.47 | $78.04 | $77.21 | 5,169,413 | 03-06-2025 |
$77.96 | $77.44 | $77.96 | $78.355 | $77.39 | 4,910,520 | 03-05-2025 |
$77.25 | $77.01 | $77.25 | $77.635 | $76.88 | 6,416,692 | 03-04-2025 |
$76.1 | $76.245 | $76.1 | $76.74 | $75.84 | 5,737,016 | 03-03-2025 |
$76.21 | $75.83 | $76.21 | $76.26 | $75.295 | 12,806,974 | 02-28-2025 |
$75.65 | $75.485 | $75.65 | $76.11 | $75.34 | 7,669,929 | 02-27-2025 |
$75.52 | $76.17 | $75.52 | $76.25 | $74.975 | 8,569,457 | 02-26-2025 |
$75.4 | $75.91 | $75.4 | $76.205 | $75.07 | 9,777,343 | 02-25-2025 |
$74.69 | $74.535 | $74.69 | $75.075 | $74.19 | 3,931,798 | 02-24-2025 |
$74.22 | $73.89 | $74.22 | $74.5 | $73.54 | 3,614,959 | 02-21-2025 |
$74.56 | $74.09 | $74.56 | $74.735 | $74.085 | 3,336,257 | 02-20-2025 |
$73.81 | $74.19 | $73.81 | $74.45 | $73.585 | 5,069,628 | 02-19-2025 |
$74.8 | $74.24 | $74.8 | $74.97 | $74.2 | 6,169,779 | 02-18-2025 |
$73.58 | $74.335 | $73.58 | $74.58 | $73.4501 | 5,783,741 | 02-17-2025 |
News, Short Squeeze, Breakout and More Instantly...
AstraZeneca PLC Company Name:
AZN Stock Symbol:
NASDAQ Market:
-0.47% G/L:
$77.60 Last:
4,848,699 Volume:
$76.87 Open:
$77.60 Close:
AstraZeneca PLC Website:
AstraZeneca and Andrews introduce SCREEN, a limited-edition t-shirt designed to spark conversation and inspire action on the benefits of early detection. AstraZeneca and Erin Andrews have teamed up as part of a national public health campaign to educate and empower people to Get B...
2025-03-08 07:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
MATTERHORN is first global, randomized Phase III trial to demonstrate superior event-free survival with an immunotherapy combination over standard of care in this setting IMFINZI plus chemotherapy more than doubled pathologic complete response rate in previously reported analysis ...